Celera and GenData in autoimmune disease pact:
This article was originally published in Clinica
Executive Summary
US firms Celera Diagnostics and GenData Research have teamed up in a project to identify genetic markers associated with an autoimmune disease. GenData, a commercial contract research and licensing partner of the University of Utah, in Salt Lake City, will provide DNA samples and associated clinical information to support Celera's marker discovery research. Last month, GenData formed a deal with Columbus, Ohio firm Battelle to discover, develop and commercialise biomarkers for diagnostic and therapeutic applications in chronic obstructive pulmonary disease.